Prev Arrow Stocks

Centene Corporation ($CNC) Stock Forecast: Up 5.4% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Centene Corporation?

Centene Corp (CNC) is a healthcare company that offers various services, including health insurance solutions. The company experienced a significant increase in the market today.

Why is Centene Corporation going up?

CNC stock is up 5.4% on May 13, 2026 14:20

  • CNC shares rose by 6.0% to $59.31, indicating a bullish market trend.
  • Despite being viewed as substantially undervalued with a GF Value™ of $84.31, there have not been recent insider transactions, suggesting a neutral stance from insiders.
  • TD Cowen emphasized positive long-term prospects for CNC, raising the price target to $48 after strong Q1 2026 results that surpassed expectations and showed substantial revenue growth.
  • Greenlight's David Einhorn recommended CNC as a long idea at the Sohn Investment conference, potentially contributing to the bullish movement and enhancing investor confidence in the stock.

CNC Price Chart

CNC Technical Analysis

CNC News

A Look at Centene Corp (CNC) After 6.0% Gain -- GF Value $84.31 vs Price $59.31

Centene Corp (CNC) shares rose 6.0%, reaching $59.31, and are considered significantly undervalued according to GuruFocus's GF Value™ of $84.31. The stock has a GF Score™ of 74/100, indicating above-average quality, with strong profitability but lower growth and valuation ranks. Despite the undervaluation, there have been no insider transactions in the last three months, suggesting a neutral outlook from insiders.

https://www.gurufocus.com/news/8853188/a-look-at-centene-corp-cnc-after-60-gain-gf-value-8431-vs-price-5931

0 Missing News Article Image A Look at Centene Corp (CNC) After 6.0% Gain -- GF Value $84.31 vs Price $59.31

Aclarion director Scott Breidbart acquires $18,011 in stock

Aclarion director Scott Breidbart purchased 5,664 shares of the company's common stock for $18,011 on May 12, 2026, increasing his direct holdings. This insider transaction occurred despite a 54% stock decline over six months, with InvestingPro suggesting the company may be undervalued. Aclarion recently reported a 196% Q1 2026 scan volume increase for its Nociscan platform, authorized a $2.5 million share repurchase, and secured a U.S. patent for its AI-based platform.

https://www.investing.com/news/insider-trading-news/aclarion-director-scott-breidbart-acquires-18011-in-stock-93CH-4682973

1 Missing News Article Image Aclarion director Scott Breidbart acquires $18,011 in stock

Is Centene Corporation (CNC) One of the Best Healthcare Stocks to Buy for the Long Term?

Centene Corporation (CNC) is presented as a strong long-term healthcare stock. TD Cowen recently increased its price target to $48 for CNC, following the company's Q1 2026 results which exceeded expectations. Centene also raised its full-year EPS guidance and reported significant revenue growth, driven by premium and membership increases in its various healthcare segments.

https://www.insidermonkey.com/blog/is-centene-corporation-cnc-one-of-the-best-healthcare-stocks-to-buy-for-the-long-term-1759717/

2 News Article Image Is Centene Corporation (CNC) One of the Best Healthcare Stocks to Buy for the Long Term?

MSCI on MSCI equity indexes May 2026 index review: all changes will be implemented as of close of May 29, 2026

MSCI announced the results of its May 2026 index review for its equity indexes, stating that all changes will be implemented at the close of May 29, 2026. For the MSCI ACWI index, 49 securities will be added and 101 will be deleted. Additionally, there will be specific changes to MSCI Frontier Markets, MSCI Global All Cap Indexes, and MSCI Global Investable Market Indexes.

https://www.marketscreener.com/news/msci-on-msci-equity-indexes-may-2026-index-review-all-changes-will-be-implemented-as-of-close-of-ma-ce7f5bdfd881f626

3 News Article Image MSCI on MSCI equity indexes May 2026 index review: all changes will be implemented as of close of May 29, 2026

Acadia Healthcare, Centene long picks by Greenlight's Einhorn at Sohn conf (ACHC:NASDAQ)

Greenlight's David Einhorn pitched Acadia Healthcare (ACHC) and Centene (CNC) as long ideas at the Sohn Investment conference. He also recommended Fluor Corp. (FLR) as a long at the same charity event.

https://seekingalpha.com/news/4591529-acadia-healthcare-centene-long-picks-by-greenlights-einhorn-at-sohn-conf

4 News Article Image Acadia Healthcare, Centene long picks by Greenlight's Einhorn at Sohn conf (ACHC:NASDAQ)

Centene Corporation Price History

01.03.2026 - CNC Stock was up 5.7%

  • Centene Corporation (CNC) is a diversified healthcare company that provides programs and services to government-sponsored healthcare programs. Today, CNC experienced a strong bullish movement in the market.
  • The bullish movement in CNC stock could be attributed to the positive sentiment in the healthcare sector following the strong performance of companies like UnitedHealth Group (UNH) and Elevance Health (ELV).
  • The current market trend could be influenced by a recent analysis suggesting UnitedHealth Group might face a significant audit exposure, indirectly boosting CNC and emphasizing strength in the industry.
  • Investor confidence in the healthcare sector, including CNC, may have been supported by a notable increase in stake in Elevance Health coupled with their positive Q4 earnings and FY 2026 guidance.
  • The overall stability and growth potential of various healthcare companies, such as HCA Healthcare Inc., likely added to the positive market sentiment, further driving CNC's bullish movement.

02.03.2026 - CNC Stock was up 5.2%

  • CNC experienced a strong bullish movement today.
  • The significant increase in stakes by HF Advisory Group LLC and Rockland Trust Co. in Elevance Health (ELV) could have positively impacted CNC's stock price, as ELV's strong financial performance and raised dividend likely boosted investor confidence in the healthcare sector.
  • Leerink's report on UnitedHealth Group (UNH) facing substantial RADV audit exposure might have indirectly benefited CNC, as investors may have shifted their focus towards other healthcare companies with potentially lower audit risks.
  • Overall, the positive sentiment surrounding healthcare stocks, driven by strong financial results and strategic investments, likely contributed to CNC's bullish market movement today.

16.03.2026 - CNC Stock was up 5.0%

  • CNC is a leading manufacturer of precision tools and equipment for woodworking and metalworking industries. The company has been expanding its product line and market presence, driving strong investor interest.
  • An announcement of a cash dividend payout by MetroCity Bankshares could have positively impacted CNC's stock, indicating a healthy financial market environment.
  • The AI arms race in the healthcare sector causing prior authorization issues and reimbursement cuts may have indirectly boosted CNC's stock as investors seek alternative industries for growth.
  • A price target adjustment on HCA Healthcare by Baird could have led investors to reallocate funds to CNC, viewing it as a more promising investment opportunity.
  • Assetmark Inc.'s increased stake in Elevance Health might have signaled confidence in the healthcare sector, indirectly benefiting CNC as part of a broader market sentiment shift.

23.03.2026 - CNC Stock was up 5.0%

  • CNC, alongside Molina Healthcare and other managed care companies, experienced a notable increase in their stock prices, suggesting a sector-wide upturn in healthcare plan providers.
  • This surge in CNC's stock was driven by general investor optimism towards the healthcare industry, rather than any company-specific developments.
  • The favorable performance of CNC could be linked to the overall positive outlook on managed care stocks and the healthcare sector at large.
  • It is advisable for investors to closely track CNC's progress and watch for any potential new drivers that could sustain or further enhance its recent gains.

29.03.2026 - CNC Stock was up 16.7%

  • Centene's Q1 2026 adjusted diluted EPS of $3.37 surpassed estimates, resulting in an increased full-year EPS forecast, indicating robust operational enhancements and effective cost management.
  • Analyst upgrades from Cantor Fitzgerald and Mizuho, coupled with favorable investor sentiment, boosted the stock's performance, showcasing belief in Centene's margin growth and overall execution.
  • Emphasis on program integrity, risk adjustment oversight, and balance sheet efficiency demonstrated Centene's dedication to sustainable expansion, meeting market expectations and driving the positive momentum in the stock.

29.03.2026 - CNC Stock was up 10.6%

  • CNC's upward momentum can be credited to its strong Q1 2026 financial results, surpassing expectations with higher adjusted diluted EPS and an upgraded full-year EPS forecast.
  • The market reacted favorably to CNC's effective management of medical expenses and trends in various segments, reflecting operational enhancements and a commitment to program integrity.
  • Investor mood was likely influenced by prominent investor David Einhorn's optimistic view on Centene Corporation, emphasizing its robust performance and improved Health Benefits Ratio.
  • CNC's surge may have also been impacted by the positive overall market sentiment towards healthcare stocks, as illustrated by the strong performance of other healthcare companies like LifeStance Health Group.

29.03.2026 - CNC Stock was up 10.4%

  • Centene Corporation (CNC) witnessed a significant bullish movement today.
  • The uptrend is believed to be a result of the company's impressive Q1 2026 earnings, surpassing expectations and leading to an upward revision of its full-year EPS forecast.
  • Positive reactions from analysts and commendations from firms like Cantor Fitzgerald, who point out a clearer route to margin enhancement, also bolstered the stock's climb.
  • Investor sentiment appears buoyant due to Centene's effective management of medical expenses, enhancements in operations, and robust performance across its primary sectors.

28.03.2026 - CNC Stock was up 5.8%

  • Centene (CNC) delivered outstanding Q1 earnings, posting a non-GAAP EPS of $3.37, significantly ahead of expectations. This impressive performance bolstered investor confidence and led to a bullish trajectory in the stock price.
  • The company generated $49.94 billion in revenue, marking a 7.1% increase compared to the previous year. Additionally, the revised guidance for the year 2026 contributed to a favorable outlook among investors.
  • Analysts responded positively, with firms such as Jefferies and BofA slightly raising their price targets, reflecting optimism in Centene's current performance and future potential.
  • The surge in Centene's stock price can be attributed to the strong earnings report, adjusted guidance, and favorable investor sentiment following strategic moves like debt repayment.

28.03.2026 - CNC Stock was up 15.3%

  • CNC stock surged over 12% today, reflecting a strong bullish movement.
  • The favorable regulatory developments for Centene, such as the approval of 2027 Medicare Advantage and Part D policies with a 2.48% payment rate increase, contributed to the positive market movement. This boosted revenue visibility and reduced regulatory risk.
  • Centene increased its profit outlook for 2026 by implementing tighter control over medical expenses and surpassing analyst expectations in Q1 2026 results. This led to higher investor confidence in the company's strategic initiatives and financial outlook.
  • Investors are optimistic about Centene's cost management efficiency and growth prospects in the healthcare sector, evident in the market's positive reaction.

28.03.2026 - CNC Stock was up 12.8%

  • CNC experienced a strong bullish movement following its Q1 2026 earnings report, which exceeded expectations across the board.
  • The company's adjusted EPS of $3.37 and revenue of $49.94 billion surpassed analyst forecasts, leading to a positive investor sentiment and a stock price increase of over 6% in pre-market trading.
  • CNC's strong performance was driven by Medicaid expansion in Texas and improved operational efficiency across its segments, reflecting the company's strategic initiatives and financial outlook.
  • Analysts responded to the earnings beat by raising price targets, indicating confidence in Centene's continued growth trajectory and market position in the healthcare sector.

13.04.2026 - CNC Stock was up 5.4%

  • CNC shares rose by 6.0% to $59.31, indicating a bullish market trend.
  • Despite being viewed as substantially undervalued with a GF Value™ of $84.31, there have not been recent insider transactions, suggesting a neutral stance from insiders.
  • TD Cowen emphasized positive long-term prospects for CNC, raising the price target to $48 after strong Q1 2026 results that surpassed expectations and showed substantial revenue growth.
  • Greenlight's David Einhorn recommended CNC as a long idea at the Sohn Investment conference, potentially contributing to the bullish movement and enhancing investor confidence in the stock.

12.04.2026 - CNC Stock was up 5.4%

  • CNC stock showed positive movement today.
  • The partnership with the Seattle Seahawks for the Strong Youth Strong Communities youth mental health summit likely enhanced positive perceptions around Centene's brand and values.
  • The robust Q1 2026 earnings report, with GAAP EPS of $3.11, highlighted the company's financial stability and potential for growth.
  • Centene's reputation as one of the top healthcare stocks for long-term investment further bolstered investor confidence, particularly due to its focus on innovative healthcare solutions and strong position in the managed care sector.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.